A laboratorian prepares a run of ARUP’s metagenomic sequencing assay. |
October 27, 2026 |
New Sequencing Technology Positions ARUP for the Future of Infectious Disease Detection ARUP has completed a CDC-funded metagenomic sequencing project that strengthens emerging pathogen |
Visit ARUP at booth #2641 to learn about the latest advancements in laboratory medicine to better support pediatric patients. |
September 28, 2026 |
Supporting Pediatric Care: ARUP To Showcase Tests at AAP 2026 Discover how ARUP is advancing pediatric care through innovations in genomics, infectious disease, allergen testing, and more |
This Newborn Screening Awareness Month, learn how updated ARUP Consult® topics support clinicians with evidence-based recommendations for diagnostic testing, monitoring, and genetic testing. |
September 16, 2026 |
In Recognition of Newborn Screening Awareness Month: Updated ARUP Consult Resources… During Newborn Screening Awareness Month, explore updated ARUP Consult® resources that |
Attendees will have the unique opportunity to tour ARUP Laboratories during the 2026 AMLI Annual Meeting. |
August 4, 2026 |
ARUP Experts To Present on Emerging Immunology Topics at the 2026 AMLI Annual Meeting ARUP pairs analytical rigor with specialty expertise in immunopathology to provide reliable |
ARUP Laboratories observed Cyclospora positivity rates increase from very low levels to unprecedented levels within a short period of time, highlighting the importance of providing clinicians and laboratorians with timely disease surveillance data, said Ben Bradley, MD, PhD, ARUP head of clinical operations for Infectious Disease. |
August 3, 2026 |
ARUP Laboratories Adds Cyclospora Data to Infectious Disease Dashboard Amid National Outbreak… ARUP Laboratories’ Infectious Disease Test Positivity Trends Dashboard now includes |
ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes small neoplastic populations with greater sensitivity than conventional flow cytometry while requiring less specimen volume. |
July 20, 2026 |
ARUP Launches First Clinical Spectral Flow Cytometry Assay for MRD Assessment in Multiple… ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes neoplastic |






















